Bone marrow represents the most frequently used tissue source of MSCs and these cells have been used in cell based therapies.
This is of interest since these cells can be used in cell-based therapy approaches.
They can be used in cell-based assays in nanomolar concentrations to increase cellular O-GlcNAc levels in vivo in a range of human cell lines.
These results suggest that the combination of outer meniscus cells and MSCs can be used in cell-based tissue engineering strategies to reconstruct the inner meniscus.
Recently, it was discovered that NAG-thiazoline, a transition state analogue, can also be used in cell-based assays to potently inhibit hOGA [20].
The most promising feature of hESCs is the ability to derive lineage-restricted progenitors that are capable of differentiating into specialized post-mitotic cell types that can be used in cell-based therapies.
These highly enriched endothelial-like cells could be directly used in cell based therapies or tissue engineering, reducing the risk of contamination from additional cell purification procedures.
In long term, this method can be extended to be used in live cell tracking in vivo, image informatics based point-of-care expert system and quantification of various complex architectures in organisms.
Still, while they cannot yet be used in living cells, Dr. Benner's artificial bases are already being used in tests that read DNA sequences.
The optical band gap of HgO nanoparticle was measured to be 2.48 eV using cutoff wavelength which indicates that HgO nanoparticles can be used in metal oxide semiconductor-based photovoltaic cells.
Analysis of the intrinsic fluorescence profiles of individual marine algae can be used in general classification of organisms based on cell size and fluorescence properties.
